InvestorsHub Logo

ssc

Followers 39
Posts 13880
Boards Moderated 1
Alias Born 12/20/2006

ssc

Re: INFINITI post# 3298

Thursday, 04/28/2022 9:27:55 AM

Thursday, April 28, 2022 9:27:55 AM

Post# of 3504
About this latest deal:

Statera entered into a non-binding term sheet with respect to a strategic agreement with Immune Therapeutics, Inc. (OTC-PINK: IMUN), a drug development and commercialization company, to sell Statera's rights to naltrexone and met-enkephalin. The transaction is contingent upon negotiation of a definitive agreement and satisfaction of a number of closing conditions, including a contingency on Immune Therapeutics financing.